Brain Cancer
May 9, 2008
Ym Biosciences Reports Fiscal Third Quarter 2008 Operational and Financial Results
“During the quarter we continued to advance nimotuzumab globally, leveraging co-operative efforts of multiple partners and other licensees of the drug”
MISSISSAUGA, ON, May 8 /CNW/ - YM BioSciences Inc. , an oncology company that identifies, develops and commercializes differentiated products for patients worldwide, today reported operational and financial ... via Canada NewsWire
Comments
Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.
| Topic | Updated | Last By | Comments |
|---|---|---|---|
| Caution on cell phone use | 29 min | Jax | 11 |
| Benefit pasta dinner set for cancer patient | Mon | dick william... | 1 |
| Letter writer sticks up for care at Veterans Af... | Jul 20 | Mutant | 1 |
| Kennedy to the rescue | Jul 14 | Simba | 17 |
| adult ependymoma | Jul 13 | barbara | 1 |
| Brain cancer strikes Sen. Kennedy | Jul 13 | Vera | 41 |
| Jaelah's Fight For Life At 9! (from Jul '07) | Jul 12 | Sarah P | 64 |
Most Popular
